Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Optimal initial dose adjustment of warfarin in orthopedic patients.

Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF.

Ann Pharmacother. 2007 Nov;41(11):1798-804. Epub 2007 Oct 2.

PMID:
17911206
2.

Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.

Enyart JJ, Jones RJ.

Ann Pharmacother. 2005 Jun;39(6):1002-7. Epub 2005 May 10.

PMID:
15886295
3.

Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.

McMillin GA, Melis R, Wilson A, Strong MB, Wanner NA, Vinik RG, Peters CL, Pendleton RC.

Ther Drug Monit. 2010 Jun;32(3):338-45. doi: 10.1097/FTD.0b013e3181d925bb.

PMID:
20386359
4.
5.

Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.

Nordstrom BL, Kachroo S, Fraeman KH, Nutescu EA, Schein JR, Fisher A, Bookhart BK.

Curr Med Res Opin. 2011 Oct;27(10):1973-85. doi: 10.1185/03007995.2011.614938. Epub 2011 Sep 15.

PMID:
21919556
6.

Fixed minidose versus-adjusted low-dose warfarin after total joint arthroplasty: a randomized prospective study.

Vives MJ, Hozack WJ, Sharkey PF, Moriarty L, Sokoloff B, Rothman RH.

J Arthroplasty. 2001 Dec;16(8):1030-7.

PMID:
11740759
7.

A safe, effective, and easy to use warfarin initiation dosing nomogram for post-joint arthroplasty patients.

Pendleton RC, Wheeler M, Wanner N, Strong MB, Vinik R, Peters CL.

J Arthroplasty. 2010 Jan;25(1):121-7. doi: 10.1016/j.arth.2008.09.015. Epub 2008 Dec 5.

PMID:
19062248
8.

The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.

Suwanawiboon B, Kongtim P, Chinthammitr Y, Ruchutrakool T, Wanachiwanawin W.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S225-31.

PMID:
21721451
9.

Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?

Le Gal G, Carrier M, Tierney S, Majeed H, Rodger M, Wells PS.

J Thromb Haemost. 2010 Jan;8(1):90-4. doi: 10.1111/j.1538-7836.2009.03676.x. Epub 2009 Oct 30.

10.

A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

Crowther MA, Ginsberg JB, Kearon C, Harrison L, Johnson J, Massicotte MP, Hirsh J.

Arch Intern Med. 1999 Jan 11;159(1):46-8.

PMID:
9892329
11.

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF.

Blood. 2007 Sep 1;110(5):1511-5. Epub 2007 Mar 26.

12.

Correlation of the change in the International Normalized Ratio and decreasing the Coumadin dosage following total joint arthroplasty.

Rosenbaum CC, Woods SE, Hasselfeld KA.

Orthopedics. 2002 Dec;25(12):1359-63; discussion 1363.

PMID:
12502198
13.
14.

Warfarin responses in total joint and hip fracture patients.

Messieh M, Huang Z, Johnson LJ, Jobin S.

J Arthroplasty. 1999 Sep;14(6):724-9.

PMID:
10512445
15.

Search for predictors of nontherapeutic INR results with warfarin therapy.

McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group.

Ann Pharmacother. 2005 Dec;39(12):1996-2002. Epub 2005 Nov 15.

PMID:
16288081
16.

Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.

Siguret V, Gouin I, Debray M, Perret-Guillaume C, Boddaert J, Mahé I, Donval V, Seux ML, Romain-Pilotaz M, Gisselbrecht M, Verny M, Pautas E.

Am J Med. 2005 Feb;118(2):137-42.

PMID:
15694897
17.

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

White RH, McKittrick T, Hutchinson R, Twitchell J.

Ann Intern Med. 1995 Jan 1;122(1):40-2.

PMID:
7985894
18.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
19.

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.

Halkin H, Shapiro J, Kurnik D, Loebstein R, Shalev V, Kokia E.

Clin Pharmacol Ther. 2003 Sep;74(3):215-21.

PMID:
12966365
20.

Clinical factors influencing the sensitivity to warfarin when restarted after surgery.

Schulman S, El Bouazzaoui B, Eikelboom JW, Zondag M.

J Intern Med. 2008 Apr;263(4):412-9. doi: 10.1111/j.1365-2796.2007.01913.x. Epub 2008 Jan 16.

Supplemental Content

Support Center